Paris Region has established itself as an area of excellence for life sciences, healthtech and artificial intelligence (AI). It is a global innovation powerhouse with a dense and dynamic ecosystem, drawing top-level international players.

A world-class scientific and medical ecosystem

For more than a century, Paris Region has been home to centers of excellence in research and healthcare. It is home to major players in the pharmaceutical and biotech industries such as Sanofi, Ipsen and Servier, as well as world-renowned research institutes like Institut Pasteur, Institut du Cerveau, Institut Gustave Roussy and Institut Curie.
Paris Region also boasts a unique hospital network with over 130 hospitals, including 38 AP-HP facilities, as well as the largest number of university hospitals in France, offering privileged access to medical advances and clinical trials.

Booming international investment

Many international players choose to invest in Paris Region to benefit from its innovative ecosystem. Kadans Science Partner and Biolabs have recently joined this European hub, developing infrastructure dedicated to innovation.

• Kadans Science Partner, specialized in scientific real estate, has opened The Hive, a campus dedicated to oncology, in Villejuif. Another large-scale project, The Mix, will be built in Paris-Saclay.
• As for Biolabs, it has chosen Hôtel-Dieu, in the heart of Paris, as the location for a healthcare innovation center in partnership with AP-HP and the University of Paris. By 2028, this 10,000 m² site will be home to around 100 startups and foster the development of new medical solutions.
• In 2024, Google opened its first French laboratory dedicated to AI, aiming to strengthen collaborations with institutions like CNRS and Institut Curie.

Paris Region, a key leader in AI and medicine

With cutting-edge infrastructure and a collaborative ecosystem, the Region has taken a leading position in the field combining AI and life sciences. Paris Region's main clusters are true hubs of innovation on a global scale. They include:

• Paris-Saclay: Cluster of excellence in AI and engineering sciences, with startups like Therapanacea and Cardiolog.
• Gustave Roussy, Villejuif: Europe's leading cancer center.
• The Genopole, Évry: France's number-one biocluster, specialized in biotechnologies.

A unique opportunity for real estate investment in the life science sector

With the rapid growth of this sector, the real estate market dedicated to life sciences in Paris Region is booming. The supply of life science real estate is set to double by 2026, and could triple by 2030.
The development of new infrastructure in Paris-Saclay, the Genopole and the south of the Paris region is designed to meet the needs of companies looking for fully-equipped laboratories and shared research facilities. There are also new opportunities with conversions of existing buildings, guaranteeing flexibility and attractiveness for investors.
Thanks to this unique ecosystem, Paris Region is now more than ever a key destination for medical innovation and investment in life sciences.